Reference-based pricing of prescription drugs
- PMID: 9039062
Reference-based pricing of prescription drugs
Comment in
-
Reference-based pricing (RBP) of prescription drugs.Can J Cardiol. 1997 Jul;13(7):689-90. Can J Cardiol. 1997. PMID: 9251582 No abstract available.
Comment on
-
A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society.Can J Cardiol. 1997 Jan;13(1):33-45. Can J Cardiol. 1997. PMID: 9039063 English, French. No abstract available.
-
Reference-based pricing in British Columbia: implications for cardiologists--an analysis.Can J Cardiol. 1997 Jan;13(1):46-51. Can J Cardiol. 1997. PMID: 9039064 Review.
Similar articles
-
A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society.Can J Cardiol. 1997 Jan;13(1):33-45. Can J Cardiol. 1997. PMID: 9039063 English, French. No abstract available.
-
The Canadian Cardiovascular Society and reference-based drug pricing.Can J Cardiol. 1998 May;14(5):669-70. Can J Cardiol. 1998. PMID: 9627521 No abstract available.
-
Coverage of drug costs: reference-based pricing.Can J Cardiol. 1998 May;14(5):666-8. Can J Cardiol. 1998. PMID: 9627520
-
Reference-based pricing in British Columbia: implications for cardiologists--an analysis.Can J Cardiol. 1997 Jan;13(1):46-51. Can J Cardiol. 1997. PMID: 9039064 Review.
-
[Rationale for the pharmacologic treatment of cardiovascular diseases].Rev Port Cardiol. 1998 May;17(5):453-61. Rev Port Cardiol. 1998. PMID: 9656768 Review. Portuguese.
Cited by
-
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD005979. doi: 10.1002/14651858.CD005979.pub2. Cochrane Database Syst Rev. 2014. PMID: 25318966 Free PMC article.
-
Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.CMAJ. 1999 Aug 10;161(3):255-60. CMAJ. 1999. PMID: 10463046 Free PMC article.
-
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.Pharmacoeconomics. 2002;20(9):577-91. doi: 10.2165/00019053-200220090-00002. Pharmacoeconomics. 2002. PMID: 12141886 Review.
-
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.CMAJ. 2002 Mar 19;166(6):737-45. CMAJ. 2002. PMID: 11944760 Free PMC article.